NFE2L2 and chronic obstructive pulmonary disease: Restoring the NOX4/Nrf2 equilibrium, either through NOX4 inhibition or antioxidant treatment, mitigates these effects, highlighting that targeting this redox imbalance represents a promising therapeutic strategy for COPD.